AzTrials
AzTrials

Intervertebral Disc DisplacementNCT03571503

The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for HLD With Radiating Leg Pain

An observational study of Intervertebral Disc Displacement and Sciatica, run by Jaseng Medical Foundation at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients receiving integrative Korean medicine treatment including Doin (conduction exercise) at a Korean medicine hospital through assessment of pain, functional disability, and quality of life. Read more about this study

Who is it for?
Ages 19 to 70 years
What is being tested?
Doin (conduction exercise), Herbal medicine and Chuna manual therapy
How many people
40 participants
Where
1 siteSouth Korea
Study dates
9 Jul 2018to 20 Sep 2019
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Herniated lumbar disc (HLD) patients with radiating leg pain

Who may be able to join

  • Inpatients with radiating leg pain distal to the gluteal fold with or without low back pain (LBP)
  • Patients with onset of radiating leg pain occurrence within the last six months, and current pain intensity of numeric rating scale (NRS) ≥5
  • Patients with disc protrusion or extrusion at the neural segment level with significant correlations with the radiating leg pain symptoms as identified on L-spine magnetic resonance imaging (MRI)
  • Patients with plans of receiving Korean medicine treatment for herniated lumbar disc (HLD) through hospitalized care
  • Patients who give voluntary written informed consent to study participation

Who cannot join

  • Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation
  • Surgery and surgical procedure in the last three weeks in areas of clinical relevance as a result of HLD
  • Patients with soft tissue pathologies or pathologies of non-spinal origin that may cause LBP or radiating leg pain (e.g. spinal tumor, rheumatoid arthritis)
  • Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, serious diabetes with risk of infection, severe cardiovascular diseases, or other conditions deemed unsuitable for acupuncture treatment)
  • Pregnant patients or patients planning pregnancy
  • Patients with serious psychological disorders
Show all 9Show fewer
  • Participating in other clinical studies other than observational studies
  • Patients unable to fill out study participation consent form
  • Subjects deemed unsuitable for study participation as assessed by the researchers

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Daejeon Jaseng Hospital of Korean Medicine

    Daejeon, 35262

Other trials in South Korea

About this study

Official title: The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for Herniated Lumbar Disc (HLD) With Radiating Leg Pain: A Prospective Observational Pilot Study

A prospective pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients receiving integrative Korean medicine treatment including Doin (conduction exercise) at a Korean medicine hospital through assessment of pain, functional disability, and quality of life.

Read the detailed description

A prospective single-center observational pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients with radiating leg pain receiving integrative Korean medicine treatment including Doin (conduction exercise) of the pelvic joint at Daejeon Jaseng Hospital of Korean Medicine through assessment of pain, functional disability, quality of life, satisfaction, and safety.

The study is expected to be performed over a period of 6 months, during the former 3 months of the study period of which the Integrative Korean medicine treatment group will be recruited, and after a wash-out period of 2 weeks, during the latter 3 months of the study period of which the Doin with integrative Korean medicine will be recruited separately.

Being tested
Doin (conduction exercise), Herbal medicine, Chuna manual therapy, Bee venom pharmacopuncture, Pharmacopuncture
Keywords
Complementary Therapies, Exercise, Acupuncture
Medical subject headings
Intervertebral Disc Displacement, Sciatica, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Doin (conduction exercise)Procedure or surgery

    Also called Doin Exercise, Do-in Exercise, Conduction Exercise

    An acupuncture physician will administer acupuncture at 4-8 acupoints in the low back and gluteal area (mandatory points: BL54, and GB30 ipsilateral to the dysfunctional site; and selective points: BL23, BL24, BL25, BL26, BL31, BL32, Ah-shi points, local acupuncture points and/or trigger points. Doin (conduction exercise) will be performed as active and passive movement with the needles in situ to the aim of effective treatment of pain and functional disability by increasing the hip joint range of motion (flexion and extension) with physician guidance and isometric resistance exercise (flexion and extension) as needed. Doin (conduction exercise) sessions will be performed 1 session/day for the duration of hospitalized treatment while the patient presents radiating leg pain (NRS≥1).

  • Herbal medicineDrug

    Also called Traditional herbal medicine

    Herbal medicine will be mainly administered in water-based decoction (120ml) and dried powder (2g) form (the ingredients are mainly, but not restricted to: Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).

  • Chuna manual therapyProcedure or surgery

    Also called Chuna manipulation, Chuna spinal manipulation

    Chuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered at the physician's discretion.

  • Bee venom pharmacopunctureProcedure or surgery

    Also called Bee venom acupuncture

    Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • PharmacopunctureProcedure or surgery

    Pharmacopuncture consisting of select herbal ingredients will be administered at Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • AcupunctureProcedure or surgery

    Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.

  • ElectroacupunctureProcedure or surgery

    Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.

  • CuppingProcedure or surgery

    Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.

  • Other intervention(s)Other

    Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.

Study groups in NCT03571503
Study groupRoleWhat they receive
Integrative Korean medicine treatmentHerniated lumbar disc (HLD) patients with radiating leg pain in the integrative Korean medicine treatment group will be administered integrative Korean medicine treatment consisting of 2 sessions/day of acupuncture, and herbal medicine, Chuna manual therapy, bee venom pharmacopuncture and pharmacopuncture, electroacupuncture, cupping, and other interventions, as needed.
Receives: Drug: Herbal medicine; Procedure: Chuna manual therapy; Procedure: Bee venom pharmacopuncture; Procedure: Pharmacopuncture; Procedure: Acupuncture; Procedure: Electroacupuncture; Procedure: Cupping; Other: Other intervention(s)
Doin with integrative Korean medicineHerniated lumbar disc (HLD) patients with radiating leg pain in the Doin (conduction exercise) with integrative Korean medicine treatment group will be administered integrative Korean medicine treatment consisting of 2 sessions/day of acupuncture, and herbal medicine, Chuna manual therapy, bee venom pharmacopuncture and pharmacopuncture, electroacupuncture, cupping, and other interventions, as needed, plus Doin (conduction exercise) for 1 session of the 2 sessions/day of acupuncture.
Receives: Procedure: Doin (conduction exercise); Drug: Herbal medicine; Procedure: Chuna manual therapy; Procedure: Bee venom pharmacopuncture; Procedure: Pharmacopuncture; Procedure: Acupuncture; Procedure: Electroacupuncture; Procedure: Cupping; Other: Other intervention(s)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Numeric Rating Scale (NRS) of low back pain

    Change in low back pain intensity at 2 weeks as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.

    Measured: Baseline, 2 weeks post-baseline

  2. Change in Numeric Rating Scale (NRS) of radiating leg pain

    Change in radiating leg pain intensity at 2 weeks as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.

    Measured: Baseline, 2 weeks post-baseline

  3. Change in Oswestry Disability Index (ODI)

    Functional disability questionnaire at 2 weeks as measured using ODI. The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP.

    Measured: Baseline, 2 weeks post-baseline

Secondary outcomes (18)
  1. Numeric Rating Scale (NRS) of low back pain

    Low back pain intensity as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  2. Numeric Rating Scale (NRS) of radiating leg pain

    Radiating leg pain intensity as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  3. Oswestry Disability Index (ODI)

    Functional disability questionnaire as measured using ODI. The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  4. Visual Analogue Scale (VAS) of radiating leg pain

    Radiating leg pain intensity as measured using VAS. VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters.

    Measured: Baseline, 3, 7, 10, 14 days post-baseline

  5. Visual Analogue Scale (VAS) of low back pain

    Low back pain intensity as measured using VAS. VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters.

    Measured: Baseline, 3, 7, 10, 14 days post-baseline

  6. EuroQol 5-Dimension (EQ-5D)

    Health-related quality of life questionnaire as measured using SF-36. SF-36 consists of 36 items across 8 domains: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. SF-36 is used to rate functional health and well-being in patients and healthy individuals. Higher scores indicate better HRQoL.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  7. Patient Global Impression of Change (PGIC)

    Global patient-reported outcome as measured using PGIC. PGIC grades the level of subjective improvement into 7 levels (1, very much improved; 2, much improved; 3, slightly improved; 4, no change; 5, slightly worse; 6, much worse; and 7, very much worse).

    Measured: Baseline, 14, 30, 90 days post-baseline

  8. Drug Consumption (drug type)

    Regarding recent use of medication, the type of prescription intake for medicine will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  9. Drug Consumption (drug intake frequency)

    Regarding recent use of medication, the frequency of prescription intake for medicine will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  10. Drug Consumption (drug intake period)

    Regarding recent use of medication, the period of prescription intake for medicine will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  11. Use of additional medical treatment (treatment type)

    Regarding current use of medical services, the type of additional medical treatment received will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  12. Use of additional medical treatment (treatment frequency)

    Regarding current use of medical services, the frequency of additional medical treatment received will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  13. Use of additional medical treatment (treatment period)

    Regarding current use of medical services, the period of additional medical treatment received will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  14. Details of Doin conduction exercise sessions (type (region))

    Administration details of Doin conduction exercise session type (region) will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  15. Details of Doin conduction exercise sessions (period)

    Administration details of Doin conduction exercise sessions (period) will be recorded.

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

  16. Lumbar range of movement (ROM)

    Physical examination

    Measured: Baseline, 3, 7, 10, 14 days post-baseline

  17. Straight leg raise (SLR) test

    Physical examination

    Measured: Baseline, 3, 7, 10, 14 days post-baseline

  18. Adverse events

    Safety outcome

    Measured: Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2018
  2. Study start9 Jul 2018
  3. Primary completion4 Jul 2019
  4. Study completion20 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
40 participants (actual)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT03571503
Sponsor's protocol ID
JS-CT-2018-02
Status last verified
Nov 2019
First submitted
1 Jun 2018
Last updated
4 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intervertebral Disc Displacement and Sciatica, run by Jaseng Medical Foundation at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Numeric Rating Scale (NRS) of low back pain (time frame: Baseline, 2 weeks post-baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in